Caitong International Asset Management Co., LTD Heron Therapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 2,838 shares of HRTX stock, worth $6,158. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,838
Previous 630
350.48%
Holding current value
$6,158
Previous $964,000
547.72%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HRTX
# of Institutions
182Shares Held
125MCall Options Held
847KPut Options Held
47.7K-
Rubric Capital Management LP New York, NY26.7MShares$58 Million1.68% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$18.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.23MShares$17.8 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.85MShares$17 Million0.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$15.2 Million26.51% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $258M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...